The medical school will welcome Karen Haas, PhD, in December as the latest speaker for Seminars in Investigative Medicine.
Dr. Haas will present “Harnessing the Protective Capacity of Innate B Cells for Anti-Tumor Responses” from noon to 1:00 p.m. on Wednesday, December 4, 2019, in TBL 2 at the W.E. Upjohn M.D. Campus in downtown Kalamazoo.
A free lunch will be available from 11:45 a.m. to noon and Dr. Haas’ presentation will begin promptly at noon. The event is free and open to the public and CE and MEDU credit is available.
If you’re interested in attending the event, please register at https://bit.ly/37gKacl.
Dr. Haas is an Associate Professor in the departments of Microbiology/Immunology and Cancer Biology at Wake Forest School of Medicine. Dr. Haas received her bachelor’s degree with a dual major in Biology and Chemistry from St. Mary’s University in Winona, Minnesota. She attended graduate school at the University of Missouri-Columbia where she studied ruminant B cell responses to pathogens under the mentorship of Dr. Mark Estes.
She received her PhD in Immunology and Microbiology in 2001 and then studied as a postdoctoral fellow and Research Assistant Professor with Dr. Thomas Tedder at Duke University Medical Center where her research focus was on B cell-directed therapies and characteristics of innate-like B cells. Dr. Haas joined the faculty at Wake Forest School of Medicine in 2009 where she is an Associate Professor and serves as Associate Director of Wake Forest’s Center for Vaccines at the Extremes of Aging.
Dr. Haas is an Associate Editor for The Journal of Immunology, serves as an ad hoc member for several NIH study sections and is a full board reviewer for the American Cancer Society’s Committee on Leukemia, Immunology and Blood Cell Development. Dr. Haas’ current research is focused on understanding mechanisms regulating innate-like B cell responses to tumors and antigen-specific B cell responses to carbohydrate antigens.
Dr. Haas is part of an impressive slate of speakers for Seminars in Investigative Medicine for the 2019-2020 academic year.
In support of improving patient care, Western Michigan University Homer Stryker M.D. School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit amount subject to change.
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
Western Michigan University Homer Stryker M.D. School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.